Significant progress has been made in understanding the molecular pathology of uveal melanoma (UM). It is well known that genetic alterations, such as monosomy 3, polysomy 8q, and BAP1 gene-inactivating mutations, are associated with a poor prognosis in UM, whereas a gain in chromosome 6p is associated with a more favorable outcome.1 However, the pathways by which these genetic aberrations influence the processes involved in tumor dissemination and ultimate colonization are not fully understood.
Coupland SE, Krishna Y. Genetic Variants of the BTNL2 Gene in Uveal Melanoma. JAMA Ophthalmol. 2016;134(10):1133–1134. doi:10.1001/jamaophthalmol.2016.2940
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: